鼻咽癌常规放疗与海马保护放疗的比较:计算机模拟研究及系统综述
该研究通过系统综述和计算机模拟剂量学研究,评估鼻咽癌海马保护放疗能否在保证靶区覆盖的同时满足危及器官剂量限值。系统综述中4项研究(n=79)显示海马保护计划将海马D40%平均从24.9 Gy降至12.6 Gy;12例患者的模拟研究中海马保护VMAT计划的海马各剂量参数均显著低于常规计划,基于NTCP模型记忆下降概率更低(p=0.002)。作者结论为鼻咽癌放疗中海马保护安全可行。
要点
- 系统综述4项研究(n=79)中,海马保护计划将海马D40%平均从24.9 Gy降至12.6 Gy。
- 12例鼻咽癌患者模拟研究中,海马保护VMAT计划海马EQD2 Dmax 23.8 Gy vs 常规46.4 Gy。
- 海马保护计划PTV覆盖与危及器官剂量相似,但PTV均匀性更差(p=0.038)。
核心结论
- 作者结论为鼻咽癌放疗中海马保护安全可行,鉴于许多鼻咽癌患者预期寿命长,认知健康在放疗计划中至关重要。
研究设计与样本
- 系统文献综述比较常规与海马保护放疗计划的海马D40%。
- 计算机模拟剂量学研究为每例患者分别制定常规与海马保护VMAT计划,遵循国际危及器官勾画、剂量优先和验收标准建议。
- 采用既往发表的正常组织并发症概率(NTCP)模型评估神经认知功能影响。
主要发现
- 系统综述纳入4项既往研究(n=79),海马保护计划较常规放疗将海马D40%平均从24.9 Gy降至12.6 Gy。
- 12例鼻咽癌患者模拟研究中,海马保护与常规VMAT计划的海马EQD2 Dmax为23.8 vs 46.4 Gy、Dmin为3.8 vs 4.6 Gy、Dmean为8.1 vs 15.1 Gy、D40%为8.3 vs 15.8 Gy,差异有统计学意义。
- PTV覆盖与危及器官剂量相似,海马保护计划PTV覆盖均匀性更差(p=0.038)。
- 基于NTCP模型,海马保护计划记忆下降概率(四分位距15.8-29.6%)低于常规计划(33.8-81.1%),p=0.002。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiation-induced damage to the hippocampi can cause cognitive decline. International recommendations for nasopharyngeal cancer (NPC) radiotherapy (RT) lack specific guidelines for protecting the hippocampi. Our study evaluates if hippocampi-sparing (HS) RT in NPC ensures target coverage and meets recommended dose limits for other at-risk organs. MATERIALS AND METHODS: In a systematic literature review, we compared hippocampal D40% in conventional and HS RT plans. In an in silico dosimetric study, conventional and HS-VMAT plans were created for each patient, following international recommendations for OAR delineation, dose prioritization and acceptance criteria. We assessed the impact on neurocognitive function using a previously published normal tissue complication probability (NTCP) model. RESULTS: In four previous studies (n = 79), researchers reduced D40% hippocampal radiation doses in HS plans compared to conventional RT on average from 24.9 Gy to 12.6 Gy.Among 12 NPC patients included in this in silico study, statistically significant differences between HS and conventional VMAT plans were observed in hippocampal EQD2 Dmax (23.8 vs. 46.4 Gy), Dmin (3.8 vs. 4.6 Gy), Dmean (8.1 vs. 15.1 Gy), and D40% (8.3 vs. 15.8 Gy). PTV coverage and OAR doses were similar, with less homogeneous PTV coverage in HS plans (p = 0.038). This translated to a lower probability of memory decline in HS plans (interquartile range 15.8-29.6 %) compared to conventional plans (33.8-81.1 %) based on the NTCP model (p = 0.002). CONCLUSION: Sparing the hippocampus in NPC RT is safe and feasible. Given the life expectancy of many NPC patients, their cognitive well-being must be paramount in radiotherapy planning.
引用
- Peternel M, Jenko A, Peterlin P, et al. Comparison of conventional and hippocampus-sparing radiotherapy in nasopharyngeal carcinoma: In silico study and systematic review. Clin Transl Radiat Oncol. 2024. PMID: 38425692. doi:10.1016/j.ctro.2024.100751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。